Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000792148 | SCV000931426 | pathogenic | PMM2-congenital disorder of glycosylation | 2018-09-17 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 1-7 of the PMM2 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 7 of the PMM2 gene. This is expected to result in an absent or disrupted protein product. Deletion of exons 1-7 has not been reported in the literature in individuals with PMM2-related disease. Loss-of-function variants in PMM2 are known to be pathogenic (PMID: 19862844). For these reasons, this variant has been classified as Pathogenic. |